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ABSTRACT 
Background: Sleep during pregnancy involves a physiological challenge to provide sufficient gas exchange to 
the fetus. Enhanced ventilatory responses to hypercapnia and hypoxia may protect from deficient gas 
exchange, but sleep-disordered breathing (SDB) may predispose to adverse events. Aim of this study was to 
analyze sleep and breathing in healthy pregnant women compared to non-pregnant controls, with a focus 
on CO2 changes and upper airway flow limitation. 
Methods: Healthy women on their third trimester and healthy non-pregnant women with normal BMI were 
recruited for polysomnography. Conventional analysis of sleep and breathing was performed. 
Transcutaneous carbon dioxide (TcCO2) was determined for each sleep stage. Flow-limitation was analyzed 
using the flattening index and TcCO2 values were recorded for every inspiration. 
Results: Eighteen pregnant women and 12 controls were studied. Pregnancy was associated with shorter 
sleep duration and more superficial sleep. Apnea-hypopnea index, arterial oxyhemoglobin desaturation, 
flow-limitation, snoring or periodic leg movements were similar in the two groups. Mean SaO2 and 
minimum SaO2 were lower and average heart rate was higher in pregnant group. TcCO2 levels did not differ 
between groups but variance of TcCO2 was smaller in pregnant women during NREM. TcCO2 profiles 
showed transient TcCO2 peaks, which seem specific to pregnancy. 
Conclusions: Healthy pregnancy does not predispose to SDB. Enhanced ventilatory control manifests as 
narrowing threshold of TcCO2 between wakefulness and sleep. Pregnant women have a tendency for rapid 
CO2 increases during sleep which might have harmful consequences if not properly compensated. 
KEYWORDS: Pregnancy, transcutaneous carbon dioxide, sleep-disordered breathing, inspiratory flow-
limitation, hypopnea, control of breathing 
 1. INTRODUCTION 
Pregnancy is a challenge for the cardiorespiratory system, particularly during sleep when the body needs to 
rest without compromising fetal oxygen supply and carbon dioxide removal. In normal pregnancy, 
breathing during sleep is well preserved [1]. Plasma concentrations of progesterone are elevated during 
pregnancy and contribute to the increased ventilatory responses to hypoxia [2] and hypercapnia [3]. 
Factors compromising breathing during pregnancy are the growing uterus that elevates the diaphragm, 
resulting in decreased functional residual capacity of the lung. The decreased tracheal traction in turn 
predisposes to upper airway narrowing, and hormonal changes increase the upper airway edema. Obesity 
during pregnancy is an additional factor predisposing to obstructive sleep apnea or snoring [4]. Breathing 
abnormalities are purported to be common during pregnancy, with partial upper airway obstruction rather 
than obstructive sleep apnea (OSA) usually observed [5]. SDB in pregnant women is associated with 
intrauterine growth retardation [[6], [7]].  
In sleep studies CO2 is rarely measured, and little is known about CO2 control during SDB, but we have 
previously shown the effect of progressively developing flow-limitation as well as steady flow-limitation on 
transcutaneous CO2 increase [[8], [9], [10]]. CO2 has been suggested to play a role in hypertension in 
preeclampsia [11]. Central chemoreceptor sensitivity to CO2 is also increased during pregnancy [3], which 
could destabilize the ventilation when operated near threshold values. 
The purpose of this study was to evaluate the differences in SDB and transcutaneous carbon dioxide 
(TcCO2) parameters during normal pregnancy compared to non-gravid controls. It was hypothesized that 
pregnant women may have more flow-limitation and snoring compared to non-pregnant women (1). In 
addition, flow-limitation in pregnant women may cause greater TcCO2 increase (2), and consequently, 
TcCO2 values during sleep should differ between pregnant and non-pregnant women (3). 
2. METHODS 
2.1 Participants 
We recruited 18 pregnant women from maternity clinics in Tampere and its nearby regions and from the 
antenatal outpatient clinic and antenatal ward of Tampere University Hospital. Inclusion criteria were 18-45 
years of age, singleton pregnancy without fetal demise, and gestational age 33±1 weeks. Women with pre-
eclampsia or other complications warranting constant monitoring and/or induction of labour were 
excluded.  
Twelve non-pregnant women with body mass index similar to that of pregnant women in the beginning of 
pregnancy were chosen as controls. These women were recruited from Tampere University of Applied 
Sciences, Medical School of University of Tampere, and Tampere University Hospital, Department of 
Obstetrics and Gynecology, using recruitment posters. The study was approved by the local Ethics 
Committee (Identification Number R12102), and all women received oral and written information on the 
trial and signed a consent form before attending. 
2.2 Obstetrical examination 
The patients were first seen by an obstetrician (R.J.) at the antenatal outpatient clinic or ward. From the 
maternity card the following baseline information (standard recordings of the first maternity clinic visit in 
early pregnancy) was obtained: initial weight, height, body mass index (BMI), initial blood pressure, and the 
results of the oral glucose tolerance test if performed. Fetal ultrasound was done using Voluson ultrasound 
equipment  (Voluson S6 ultrasound, GE Healthcare, CT, USA) to record a fetal weight estimate, amniotic 
fluid index (AFI), fetal movements, and to assess the flow of the umbilical artery (uA). After a minimum of 
15 minute rest in a supine position in the examination room, blood pressure was measured from the right 
arm using a validated oscillometric technique (Omron automated manometer, M4-I Intellisense, Omron 
Corporation, Japan) with medium cuff-size. Weight was measured on a regular weighing scale. Urine dip 
stick test was analyzed for protein and glucose (Combur3 Test, Roche Diagnostics, Germany).  
2.3 Sleep recordings 
An overnight polysomnography was performed at Unesta Research Centre within a week after the 
obstetrical examination in the pregnant group. Controls visited the sleep laboratory once and all the 
information needed was then gathered. Recording montage contained electroencephalogram (EEG) with 8 
–channels (A1,A2,O1,O2,F3,F4,C3,C4), electro-oculogram (EOG), submental electromyography (EMG), 
anterior tibial EMG, nasal flow (prongs/cannula), body position, and inductance plethysmography (RIP) 
belts, which reflect the respiratory effort of the abdomen and thorax (Somnologica, Medcare Flaga hf, 
Reykjavik, Iceland). The sleep investigations included also nocturnal measurement of transcutaneous partial 
pressure of carbon dioxide (TcCO2) and transcutaneous partial pressure of oxygen (TcO2). A parasternally 
fixed dual sensor (TcCO2 and TcCO2) warmed up to 43.0°C was used (TCM4, Radiometer, Copenhagen, 
Denmark). 
2.4 Data analysis 
Sleep was scored according to AASM (American Academy of Sleep Medicine) criteria [12], and former 
stages S3-S4 were used in the breath-by-breath analysis. Proprietary scoring function of Somnologica was 
used to score flow limitation and snoring (default flattening index of 0.13 was used) and reported as 
percentage of total sleep time. Episodes of apnea were scored according to AASM rules [13], hypopnea was 
scored when a 30% reduction of flow was observed for a minimum of 10 seconds and apnea-hypopnea-
index (AHI) was calculated. Oxyhemoglobin desaturations of 3% (ODI3) or more were tabulated. 
Transcutaneous CO2 values were sampled with the frequency of 1 Hz and the data values during each sleep 
stage were pooled to calculate the statistics, including the median and quartiles for each sleep stage. This 
means that each epoch produced 30 data points to corresponding sleep stage data pool. TcCO2 values were 
also determined separately during inspirations with and without flow-limitation in each sleep stage. For this 
respiratory analysis the TcCO2 data was advanced 30 seconds in order to correct the physiological delay 
between breathing and the CO2 reading on the skin. In addition, to avoid the disproportionately marked 
effect of individuals with low levels of flow-limited breathing on overall data, the TcCO2 data was excluded 
from this analysis if less than 75 data points were available in a given sleep stage. One to two data points 
were available from each inspiration. Accordingly, short episodes (less than 3-5 min, depending on 
respiratory rate) of flow-limitation were not included. Poor quality TcCO2 data (missing, unphysiological 
behavior and drift more than 1 kPa between evening and morning wakefulness for sleep stage analysis) as 
well as data during calibrations were omitted. TcCO2 drift corrections were not done. Technical drift occurs 
both upwards and downwards, which results a reduced effect of signal drift on a group level, but at the 
same time increases the variance of the sample which affects statistical analysis. 
2.4.1 Peak analysis 
The overnight profile revealed TcCO2 fluctuations, which have not been reported or identified earlier in any 
other patient population or healthy controls. Based on initial visual observation a set of rules to identify 
and numerically characterize these events were established. A TcCO2 peak was scored when a sudden 
TcCO2 increase followed by decrease to baseline was observed. Since no guidelines exist for scoring this 
type of event, TcCO2 increase of more than 0.1 kPa was chosen as a loose criterion to score a TcCO2 peak. 
For exclusion of clear episodes of apnea and hypopnea, minimum event duration was set to 1 minute and 
30 seconds. Peaks during rapid eye movement (REM) sleep were excluded due to normal ventilatory 
instability and fluctuating TcCO2 that is commonly seen. Sleep state was required for the peak to be scored 
and peak events containing two or more consecutive epochs of wakefulness were excluded. Association to 
arousal or respiratory arousal was also scored. Respiratory arousal was scored when inspiratory flow shape 
improved simultaneously with arousal. The start of the peak was marked when TcCO2 slope started to 
increase. The end of the event was marked when TcCO2 returned to starting value or slope returned near 
zero (applied when the peak ended at higher TcCO2). Signal drift was considered insignificant during these 
shorter events. 
2.5 Statistics 
The data were analyzed using SPSS (IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp.). 
The differences between pregnant and controls were analyzed with independent samples Mann-Whitney U 
test. Non-parametric tests were used due to small sample size and skewed distributions. Results are 
expressed as medians with interquartile range (IQR) except for age and BMI where full range is shown. 
Pearson’s chi-square test was used to test the prevalence of peaks between groups. Non-parametric 
Levene’s test was used to compare the variance of TcCO2 between groups in different sleep stages. A p-
value of <0.05 was considered statistically significant.  
3. RESULTS 
3.1 Obstetrical characteristics  
Study enrollment ran from 1.1.2013 to 31.12.2015. Findings on general physical and obstetrical 
examination were normal. All subjects were normotensive without proteinuria. All fetuses presented with 
normal bioprofiles in ultrasound examination. The outcomes of the pregnancies were analyzed (possible 
complications during pregnancy, time and mode of delivery, birthweight, Apgar scores at 1 and 5 minutes, 
umbilical artery pH and base excess). Fourteen patients delivered vaginally and four via caesarean section. 
Gestation at birth ranged from 37+3 to 42+0 weeks. Obstetrical characteristics are presented in Table 1.  
3.2 Sleep and demographics 
The control population was younger than the pregnant population (26, range: 24-31, vs. 30, range: 26 -36, p 
< 0.001). There was no difference in BMI in the beginning of pregnancy compared to controls (22.0, range 
19.0 – 29.4, vs. 21.7, range: 18.8 – 25.4, p = 0.245). Sleep quality of the pregnant women was worse 
compared to controls. Pregnant women had more light sleep (N1) and less deep sleep (N3) and REM sleep. 
Also, total sleep time (TST) was shorter and wake after sleep onset (WASO) was longer in pregnant women. 
Clear difference between groups was seen on oxyhemoglobin parameters (SaO2), which were lower in 
pregnant women. Considerable increase in average heart rate was observed in pregnant women also. 
Common sleep-disordered breathing parameters AHI and ODI3 showed no difference. Additional measures 
that were used (FL-index (%) and snore time (%)) did not show statistical difference. Two pregnant subjects 
and one control subject were identified as significant snorers with episodes of prolonged flow limitation. 
Detailed values are presented in Table 2. 
Table 1. Obstetrical characteristics of 18 healthy pregnant women participating in the sleep study. 
Subject Age P US RR BMI Del Mode Sex BW Apgar uApH 
1 36 2 34+6 130/75 25.7 40+3 V Boy 3740 9/9 7.28 
2 29 1 32+1 108/69 27.3 39+4 V Boy 3605 9/10 7.26 
3 29 0 31+4 112/72 21.0 42+0 V Girl 3300 9/9 7.28 
4 36 2 33+2 118/82 NA 39+1 CS Boy 3470 9/9 7.37 
5 31 0 33+2 102/67 21.6 40+6 CS Girl 3740 9/9 7.34 
6 36 0 33+0 122/71 25.8 40+2 V Boy 3650 8/9 7.21 
7 36 2 32+6 124/79 27.7 39+0 V Boy 3120 9/9 7.19 
8 29 0 32+6 121/72 29.4 40+1 CS Girl 3080 9/8 7.34 
9 29 0 32+3 99/51 25.0 41+3 V Girl 3260 7/8 7.17 
10 29 3 32+4 104/58 19.2 39+0 V Girl 3195 9/10 7.24 
11 31 1 32+4 120/76 33.0 38+3 V Boy 3800 9/9 7.17 
12 30 1 31+4 112/84 22.0 39+3 V Boy 3920 8/9 7.30 
13 29 0 34+0 108/72 28.0 41+1 CS Girl 4480 8/8 7.36 
14 30 0 31+2 118/74 21.6 39+6 V Boy 3255 7/9 7.13 
15 35 0 32+4 112/70 19.2 37+3 V Girl 2385 8/8 7.17 
16 34 0 31+5 113/77 19.0 41+1 V Girl 3340 8/9 7.28 
17 30 0 33+4 110/80 23.0 39+4 V Girl 3250 6/9 7.20 
18 26 0 34+0 124/74 22.0 42+0 V Girl 4190 9/9 7.20 
P=parity; US=ultrasound scan; RR=blood pressure at ultrasound visit; BMI=body mass index in the 
beginning of pregnancy; Del=gestation at delivery, weeks+days; Mode=mode of delivery; V=vaginal; 
CS=ceasarean section; BW=birth weight (grams); Apgar=Apgar score 1 min/5 min; uApH=umbilical artery 
pH at birth; NA=not available 
 
 
 
 
 
 
 
 
 
 
 Table 2. Polysomnography data 
  Pregnant Controls P 
  median (Q1-Q3) median (Q1-Q3)   
TST (min) 361.0 (330.5 – 418.9) 415.5 (391.5 – 429.4) 0.007 
Sleep onset (min) 17.5 (11.5 – 27.6) 21.5 (15.1 – 27.0) 0.518 
WASO (min) 110.5 (58.5 – 151.1) 39.7 (21.8 – 77.0) 0.003 
Sleep Efficiency (%) 76.7 (68.3 – 88.6) 91 (85.0 – 95.0) 0.002 
N1 sleep (min) 30.3 (25.5 – 45.3) 21.0 (16.3 – 30.8) 0.004 
N2 sleep (min) 141.8 (96.0 – 168.0) 140.5 (109.9 – 174.0) 0.884 
N3 sleep (min) 118.5 (97.5 – 143.6) 156.5 (133.3 – 190.8) 0.009 
REM sleep (min) 53.0 (40.3 – 69.5) 91.5 (73.5 – 99.6) 0.001 
AHI (#/h) 1.55 (0.73 – 3.25) 0.75 (0.23 – 1.45) 0.124 
ODI3 (%) 0.4 (0 – 2.1) 0.2 (0 – 0.38) 0.200 
SaO2 mean (%) 95.9 (95.2 – 96.3) 97.5 (96.1 – 97.9) <0.001 
SaO2 min (%) 93.0 (91.5 – 94.0) 94.5 (93.3 – 95.8) 0.008 
FL-index (%) 11.3 (6.1 – 23.6) 10.10 (6.3 – 18.4) 0.573 
Snore time (%) 0 (0 – 0.33) 0 (0 – 0.08) 0.914 
PLM (#/h) 2.4 (0 – 5.2) 0.5 (0 – 1.4) 0.296 
Avg. HR (bpm) 71.7 (64.3 – 79.0) 59.6 (55.7 – 66.9) 0.002 
Data presented with medians and IQR. TST = total sleep time, WASO = wake after sleep onset, N1,N2,N3 = 
Non rapid eye movement (NREM) sleep, REM sleep = rapid eye movement sleep, AHI = apnea-hypopnea-
index, ODI3 = oxyhemoglobin desaturation for 3% or more, FL-index = percentage of flow limited breaths 
during sleep, PLM = periodic leg movements, Avg. HR = average heart rate. 
 
3.3 TcCO2 
In terms of TcCO2 levels (absolute or relative) there were no differences in TcCO2 between the pregnant 
and control group in any of the sleep stages (Table 3). In general, the pregnant women had a wider range 
for TcCO2 when absolute values were used. However, we discovered that in pregnant women the variance 
of TcCO2 across sleep stages became smaller for NREM when TcCO2 during wakefulness was used as the 
reference value (Table 3 and Figure 1). Sleep stage and TcCO2 analysis was possible only for 15 pregnant 
and 8 non-pregnant women due to TcCO2 signal drift and poor data in three pregnant woman and four 
controls. Inspiratory flow-limitation did not cause greater TcCO2 increase in pregnant women compared to 
controls in any of the sleep stages (data not shown). 
 
 
 
 
 Table 3. Absolute and relative transcutaneous CO2 data for sleep stages 
  Pregnant (N=15) Controls (N=8) p p (variance) 
  median (Q1-Q3) median (Q1-Q3)     
TcCO2, absolute (kPa) 
Wake 6.19 (5.41 – 6.65) 6.16 (5.96 – 6.51) 0.776 
N1 sleep 6.28 (5.35 – 6.75) 6.49 (6.04 – 6.74) 0.428 
N2 sleep 6.28 (5.43 – 6.75) 6.57 (5.97 – 6.89) 0.392 
N3 sleep 6.32 (5.92 – 6.65) 6.52 (5.97 – 7.08) 0.506 
REM sleep 6.41 (5.28 – 6.95) 6.39 (5.72 – 6.78) 0.825 
NREM sleep 6.29 (5.48 – 6.67) 6.56 (5.98 – 7.01) 0.357  
ȴTcCO2 (kPa) 
Wake (reference) 0 0 - 
N1 sleep 0.08 (-0.03 – 0.18) 0.20 (0.03 – 0.61) 0.115 0.323 
N2 sleep 0.12 (0.05 – 0.29) 0.24 (-0.04 – 0.65) 0.506 0.213 
N3 sleep 0.15 (0.08 – 0.38) 0.21 (0.04 – 0.53) 0.825 0.075 
REM sleep 0.15 (0.08 – 0.43) 0.16 (- 0.15 – 0.49) 0.925 0.067 
NREM sleep 0.11 (0.07 – 0.22) 0.24 (0.03 – 0.62) 0.506 0.038 
Data presented with medians and IQR. TcCO2 = transcutaneous carbon dioxide, NREM = non-rapid eye 
movement, REM = rapid eye movement, p (variance) denotes Levene’s test. 
 
 
Figure 1. Relative TcCO2 in pregnant and controls during different sleep stages. Wakefulness was assigned 
as 0 kPa and sleep stages are relative to that. TcCO2 levels did not differ between groups, but the variance 
(Levene´s test) was different for pooled NREM. Boxplots show median values with inter-quartile range and 
min-max. Circle denotes outlier. 
3.3.1 Transcutaneous carbon dioxide peaks 
A further look into TcCO2 overnight profiles of the pregnant group showed a number of distinctive peaks 
(Figures 2 and 3), which are not commonly seen in overnight profiles of non-pregnant subjects. Eleven of 18 
pregnant women had these peaks, whereas 4 of 12 non-pregnant women had similar TcCO2 peaks (p = 
0.136). Altogether, only 5 peaks were observed in the control population versus 78 peaks in the pregnant 
population (0.42 peaks/person in controls vs. 4.33 peaks/person in pregnant, p= 0.028) rendering the peaks 
approximately 10-times more frequent in the pregnant population. Mean amplitude of the peak was 0.20 
kPa with duration of 241 seconds (range 92 – 430 seconds). Mean slopes were 0.11 kPa/min upwards and 
0.09 kPa/min downwards. When present, the number of peaks per person ranged from 2 to 22 in pregnant 
women. Fifty-two TcCO2 peaks (62.7 %) were associated with clear inspiratory flow-limitation (Figure 2). 
Respiratory arousal was associated with 14 peaks and arousal with 37 peaks. Amplitude criterion of 
hypopnea was reached in 24 peaks and apnea in one peak. Oxyhemoglobin desaturation of 3 to 4 % was 
associated with 8 events.   
 
Figure 2. Three examples of overnight TcCO2 profile with hypnogram. For drift assessment, we expect that 
the wakefulness tcCO2 should be the same in the evening and in the morning. Also, the plateau levels 
during SWS should repeat at about same levels. A) A pregnant woman with TcCO2 peaks (arrows) 
associated with short episodes of flow-limitation. Overnight flow-limitation index was 4.3 %. Downward 
trend of the signal is considered physiological, related to respiratory stimuli from circadian process and/or 
sleep fragmentation. B) A pregnant woman with TcCO2 peaks (arrows) without flow-limitation episodes. 
Overnight flow-limitation index was 4.7 %. A minor upwards drift is probable, since the wakefulness levels 
are higher in the morning. The lower fluctuating tcCO2 level during the early part of the recording seems to 
hinder tcCO2 increase to the so called plateau level during SWS, so drift may seem more accentuated than 
what it really is. C) A control woman without any TcCO2 peaks. Overnight flow-limitation index was 3.1 %.  
Decreasing trend of the plateau levels and evening/morning wakefulness levels suggest a technical drift. 
Figure 3. A pregnant woman with two transcutaneous CO2 peaks associated with flow-limitation episodes. 
Upper left panel shows the hypnogram (A). Upper right panel shows the overnight TcCO2 (B). Bottom panel 
(C) shows a detailed 18-minute time window, from darkened area shown in upper panels. Traces: SaO2 (%)  
= arterial oxyhemoglobin saturation; TcO2 (kPa) = transcutaneous partial pressure of oxygen; TcCO2 (kPa) = 
transcutaneous partial pressure of carbon dioxide; Flow (ml/s) = flow at nasal prongs. 
 
4. DISCUSSION 
We studied sleep and breathing parameters in 18 healthy women during pregnancy weeks 31-34, and in 12 
healthy non-gravid controls. Pregnant women slept less and stayed less time in slow wave sleep and REM 
sleep. No difference was observed between groups in terms of flow-limitation or snoring, AHI or PLM. 
However, pregnant women had lower average and minimum SaO2 levels and increased heart rate. 
Unexpectedly, the TcCO2 levels showed no difference between groups during different sleep stages, only 
the variance of NREM TcCO2 was smaller in the pregnant group. These findings suggest that the TcCO2, 
which represents the peripheral pCO2 at the tissue level, remains unchanged and is carefully controlled 
during pregnancy. The most intriguing finding of our study was that more than half of the pregnant women 
presented with transient TcCO2 increases in a pattern that to our knowledge has not been previously 
described in any other control or patient population. Post-hoc analysis showed that most of these TcCO2 
increases were associated with transient episodes of inspiratory flow-limitation, although in some pregnant 
women flow limitation was absent. The transient TcCO2 increases in pregnant women are in contrast with 
otherwise strictly controlled TcCO2 and may reveal episodes when the maintenance of homeostasis is 
challenged.  
Our study corroborates previous findings that sleep quality is diminished during pregnancy [14]. Total sleep 
time was shorter with 40 minute reductions in N3 and REM sleep and increase in N1 sleep. We showed that 
breathing is only minimally disturbed in late pregnancy, a finding that has been reported several times 
before. A recent study performed by Sarberg et al. [15] had a similar, albeit larger, healthy study population 
with comparable results of very low levels of AHI, ODI and nadir SaO2 from the respiratory recordings. We 
observed lower levels of snoring than have been previously reported, but this difference may result from 
methodological differences.  
The average SaO2 during sleep was lower in pregnant women compared to the controls. This is in line with 
earlier findings showing progressively decreasing PaO2 levels [16] from second to third trimester of 
pregnancy seen in supine position. The fact that PaO2 does not decrease during pregnancy in sitting 
position [16] suggests that also the lower SaO2 in our study during sleep is associated with body position 
and the progressive impact of elevating diaphragm on functional residual capacity (FRC) and oxygenation 
[17]. The cardiac output increases during pregnancy [18] but also becomes sensitive to body position 
suggesting compression of inferior vena cava by uterus [19]. Decreased venous return to the heart could 
contribute to the observed increasing heart rate in the third trimester since stroke volume decreases from 
the second trimester [18]. 
The role of CO2 in SDB during pregnancy has been speculated [[11], [20]], as well as in preeclampsia [11]. 
CO2 measurements are not routinely measured during adult sleep studies [21], mainly due to lack of simple, 
robust and noninvasive methods of CO2 monitoring. The reference measurement is partial pressure of the 
arterial CO2 (PaCO2), which is a reliable measure of ventilation but requires blood samples and is not 
suitable for sleep studies. End-tidal CO2 (EtCO2) is noninvasive and allows for continuous monitoring of the 
mixed venous CO2 provided that the tidal volumes are sufficient to produce readable end-tidal CO2-plateau: 
this may be a challenge in subjects with mouth breathing, sleep-disordered-breathing, nocturnal 
hypoventilation or usage of CPAP mask, which is often the case in subject whom this type of measurement 
is indicated [13].  
Transcutaneous carbon dioxide measurement is probably best adapted for sleep recordings. It reflects both 
ventilation and peripheral blood perfusion [[22], [23]]. The main issues with TcCO2 are slow response time 
and potential signal drift during prolonged recording [[24], [25]]. The overnight tcCO2 profiles can display 
either technical drift or physiological trends. The technical drifts can be related to changes in the contact 
between the sensor and the skin after changes in body position but may also occur within the sensor. The 
physiological trends arise from changes in control of breathing and circulation at the system level or 
changes in metabolism and blood perfusion locally. The tcCO2 signal is a combination of ventilation at 
system level and perfusion at local level, which are both under control of the sympathetic nervous system. 
The sympathetic tone from hypothalamic origin displays a circadian rhythm with high tone during 
wakefulness and a nadir tone around 03-04 am. During the morning hours this sympathetic tone starts to 
increase and is potentially reflected as a decreasing trend in tcCO2, as superficial skin perfusion starts to 
increase. A physiological trend may also occur, if the proportion of SWS decreases and the proportion of 
sleep stages N1-N2, REM or wake increase as they often do during the latter part of the night. This is the 
likely explanation of decreasing trend in Figure 2 panel A, since the wakefulness levels are the same before 
sleep onset and after sleep. Frequent arousals from sleep decrease the tcCO2 (hyperventilation) whereas 
periods of upper airway flow-limitation increase it (hypoventilation). Long or repeated periods of flow-
limitation may also cause a physiological tcCO2 increase over time. In the populations of the current study, 
prolonged flow-limitation was rare and its contribution to tcCO2 trends was unlikely. We conclude that at 
present, it is not possible to distinguish between technical and physiological trends. Therefore, we 
preferred only to exclude cases with extreme trend/drifts but include signals with limited drift. 
We are not aware of previous reports of TcCO2 during sleep in pregnancy. Therefore, we can only compare 
our results with studies using other methods, including also measurement while awake. It is well 
established that the minute ventilation increases and PaCO2 decreases during pregnancy [26]. This effect is 
considered as an exaggeration of ventilation to ensure sufficient gas exchange to the fetus and is at least 
partly driven by increasing levels of progesterone during pregnancy [3]. Against our expectations, we failed 
to show decreased TcCO2-levels in pregnant women. There are several possible explanations for this 
observation. First, the sensitivity or accuracy of the TcCO2 method is not sufficient to demonstrate 
difference. This interpretation is not supported by the observed lower variance in our larger study group 
(15 pregnant women vs. eight controls), which may reflect increased chemoreceptor sensitivity [3]. The 
PaCO2 increases during sleep [27] but decreases during pregnancy while awake [26]. When using tcCO2, we 
see sleep-related increase but not pregnancy-related decrease while awake (Table 3), which should be of 
about similar magnitude. This suggests that the effects of sleep and pregnancy on the TcCO2 are mediated 
through different mechanisms. One possible explanation for similar TcCO2 values could be that the TcCO2 
measures the combination of the increased metabolic rate with increased CO2 production and decreased 
PaCO2, resulting in no change. However, the lower partial pressure of CO2 in the arteries and higher heart 
rate during pregnancy could represent adaptive measures to maintain constant pCO2 at the tissue level. 
Discovering the TcCO2 peaks in the healthy pregnant women (but not in controls) is new and seems 
contradictory in relation to the mechanisms mentioned above. One would assume that changes in TcCO2 
should be minimal. Yet, visually detectable transient TcCO2 increases are common pregnancy specific 
findings. The transient TcCO2 increases with upper airway flow limitation can be explained as obstructive 
events. Partial upper airway collapse decreases minute ventilation, which results in transient CO2 increase 
followed by corrective response. We have previously shown that upper airway flow limitation during sleep 
is associated with increasing TcCO2 [[8], [9]]. There are several reasons for upper airway narrowing during 
pregnancy, including upper airway edema and decreased tracheal traction due to pregnancy induced 
elevation of the diaphragm. On the other hand, tight respiratory control during pregnancy ensures that the 
minor upper airway obstructive event is promptly corrected and does not develop into an episode of 
obstructive sleep apnea. Examples of transient TcCO2 increases with flow limitation are presented in Figure 
2A and Figure 3. These episodes may play a role in pre-eclampsia [11]. 
In contrast to TcCO2 peaks associating with flow-limitation, in some individuals the phenomenon is more 
likely to be associated with unstable respiratory control. Different type of TcCO2 pattern is seen in Figure 
2B. This fluctuation was counted as peaks, but since flow-limitation is not observed it can be speculated 
that ventilatory plant gain is increased (small changes in ventilation cause augmented CO2/O2 response). 
Slight fluctuation of ventilation is observed during these peaks in slow-wave sleep which indicates an 
overall increase in loop gain, as ventilation during slow-wave sleep is usually very stable. Respiratory 
stimulation during pregnancy probably prohibits the development of (central) apneic behavior because 
reaching the apneic threshold would require further increase in ventilation [27]. In fact a recent study 
showed that central sleep apnea is almost non-existent during late pregnancy [20]. This could also explain 
why the observed large fluctuations in TcCO2 are accompanied by very little waxing and waning behavior. In 
our previous studies we have used the concept of TcCO2 plateau to describe optimal TcCO2 during sleep 
and normal breathing [9]. If this level is exceeded, respiratory efforts increase. Figure 2A represents this 
idea well during the first sleep cycle; flow-limitation causes upward deviation of the TcCO2 from the target 
level, but compensatory mechanisms quickly restore the optimal level. On the other hand, if a disturbance 
such as an arousal decreases CO2 from the target level, the ventilation is repressed in order to restore that 
optimal level. Extreme case is the momentary repression to zero when apneic threshold is reached. 
Pregnant woman in figure 2B presumably fluctuates around the plateau level since there is neither flow-
limitation nor hypopneic breathing present. Our results show the dynamic behavior of CO2 during sleep in 
pregnancy, which could benefit the understanding of SDB during this vulnerable state. It remains to be 
investigated whether the CO2 events observed here are prolonged or exaggerated in risk populations and 
how they may contribute to pathophysiological processes. 
The strength of this study is the use of overnight TcCO2 measurement and a healthy population. Changes 
that are seen in TcCO2 profile should be considered as normal findings, which is useful when TcCO2 is 
measured in high-risk populations or in pre-eclamptic patients. In addition, a full polysomnographic 
recording allowed detailed determination of sleep. Determination of PaCO2 during sleep would have been 
informative, but being invasive and uncomfortable procedure it would have disturbed sleep unduly. EtCO2 
measurement would have also been useful, but was not available for this study. The number of subjects in 
this exploratory study is quite small and thus decreases the statistical power. However, recruitment of 
women for an overnight sleep recording in late pregnancy is challenging, particularly when there exists no 
previous measurement standards for all the events. Hence, a novel method for scoring TcCO2 peaks was 
developed and used in this study. 
Our approach for respiratory analysis has limitations, which should be considered when evaluating the 
data. First, the use of automated scoring function for breathing may not be optimal, but subject-to-subject 
variation is minimal and systematic error is similar between subjects. Second, the TcCO2 signal is known to 
drift and this will have an effect if normal breathing and flow-limited breathing occur at different times 
during the night. In order to counter this effect, data with large differences between the evening and 
morning were discarded. Also, large fluctuations in TcCO2 signal without any discernible change in 
ventilation were considered erroneous. Some individuals had virtually no flow-limitation and in order to 
avoid overrepresentation in the data, data from sleep stages with small amounts of flow-limited breathing 
were excluded.  
For the analysis of sleep stage tcCO2 the data was pooled from the whole night to give a sleep stage specific 
tcCO2 value. In the case of signal drift this approach is problematic since it introduces bias. Signal drift 
downwards will give too low values and upward drift will give too high tcCO2 values. Technical drift 
however, occurs in both directions and when the data is analyzed on a group level the effect of drift is 
diminished to some extent. Unfortunately the variance is increased at the same time, which makes it more 
difficult to see statistical differences between groups. This may explain why we failed to see differences 
between sleep stages. Despite of these limitations we see that our data gives a detailed view of overnight 
CO2 dynamics that should be further studied. 
Our results open new perspectives to cardiorespiratory monitoring during sleep and pregnancy. In healthy 
individuals, even subtle changes in ventilation may lead to notable changes in TcCO2. Our subjects were 
healthy and had a relatively low level of sleep-disordered breathing, but in individuals with complicated 
pregnancies upper airway flow-limitation could result in marked (Tc)CO2 changes affecting heart and 
endothelial function. CO2 increase related to flow-limitation may contribute to overnight increase in blood 
pressure [11] that is reversible with treatment. Identification of clinically significant TcCO2 patterns could in 
the future guide to treatment decisions in symptomatic patients with low AHI. Flow limitation can be 
effectively controlled with CPAP (continuous positive airway pressure), a mode of therapy which helps to 
stabilize CO2 levels and sleep. 
5. CONCLUSIONS 
In conclusion, during normal pregnancy sleep-disordered breathing is very mild and comparable to non-
pregnant controls. In contrast to the earlier findings of decreased PaCO2 during pregnancy, the absolute 
levels of TcCO2 showed no difference between the groups. However, the variance of TcCO2 is smaller in the 
pregnant group when relative values are used. We suggest that the decreased PaCO2 during pregnancy is 
an adaptive measure to maintain constant pCO2 at the tissue level. Transient changes are seen in overnight 
TcCO2 profile, which reflects altered respiratory control. Further studies with a larger population are 
evidently needed in the field of sleep disorders during pregnancy and different pregnancy complications. 
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